News archive

From the 31 January 2023, all new clinical trials shall be registered in the EU-joint web portal Clinical Trials Information System (CTIS). CTIS is replacing the old web portal EudraCT. Everything regarding the clinical trial is now managed in one system, compared to the previous procedure for clinical trials applications.

We congratulate the research group Clinical Physiology at the Department of Molecular Medicine and Surgery, where a total of five researchers were granted millions from the Swedish Research Council and the Heart-Lung Foundation 2022.

Clinical Studies Sweden launches a new national web page to support clinical studies in Sweden. The web page is aimed at researchers, research staff and life science companies that conduct clinical studies in healthcare. On the web page you can find support, services, training and information about the clinical trial units.

The two-day conference, Collaboration in Science 2022, is held on 6 and 7 October at KI’s Campus Flemingsberg. During the conference, participants will learn about the extensive research being conducted at Karolinska Institutet and Karolinska University Hospital.

We congratulate these researchers at MedH and Campus Flemingsberg who are the recipients of the CIMED project grants 2023-2025.

Congratulations to the researchers at BioNut who received funding from CIMED for 2023-2025.

Researchers at Karolinska Institutet have identified eight primary factors that increase the risk of a common bleeding complication after heart attack. Some of these factors are already known, but using machine learning techniques, the researchers have found additional predictors, such as smoking, blood pressure and blood glucose.

Congratulations to the researchers at BioNut who received funding from CIMED for 2022-2024. A total of 4.5 million SEK awarded.

More than 1,200 people with rare diseases have received a diagnosis thanks to the integration of large-scale genomics into the Stockholm region’s healthcare system. This is according to a study from Karolinska Institutet in Sweden that analysed the result of the first five years of collaboration on whole genome sequencing between Karolinska University Hospital and SciLifeLab. The work, published in Genome Medicine, constitutes a major leap forward in the emerging field of precision medicine.

Researchers at Karolinska Institutet in Sweden have carried out the first randomised trial of civilians with acute conflict-related wounds at two hospitals in areas affected by armed conflict. The study, which is published in The Lancet Global Health, shows that a new, more costly method of wound treatment is not more effective than standard treatment. The researchers hope to inspire new research projects in conflict zones that could improve the care for these vulnerable patients.

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the only effective treatment available for the most seriously afflicted patients. A clinical trial conducted in collaboration with researchers at Karolinska Institutet in Sweden now shows that a new drug candidate can prevent attacks in these patients. The study is published in The New England Journal of

A report from the Swedish Research Council shows that the clinical research conducted in collaboration between Karolinska Institutet (KI) and Stockholm County Council (SLL) maintains a very high level of quality.

Researchers at Karolinska Institutet have explored NK cell-based immunotherapy on patients with treatment-resistant leukaemia. The study, which is published in the scientific journal Clinical Cancer Research, shows that the new therapy is effective against several types of leukaemia.

Infections in surgically implanted heart valves are more common in patients who have been given a biological prosthetic valve than in those with a mechanical one, a study from Karolinska Institutet published today in the journal Circulation shows.

Acupuncture has no effect on involuntary childlessness caused by polycystic ovary syndrome (PCOS), the most effective treatment for PCOS being the drug chlomiphene, a joint international study conducted at Heilongjiang University of Chinese Medicine, China, reports. The study, which involved the participation of researchers at Karolinska Institutet, is published in JAMA.